These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 707522)

  • 21. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of clonidine (Haemiton) on plasma renin level and angiotensin sensitivity in man.
    Gachályi B; Káldor A
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):433-6. PubMed ID: 700917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.
    Geyskes GG; Boer P; Vos J; Dorhout Mees EJ
    Lancet; 1976 May; 1(7968):1049-51. PubMed ID: 57453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How to advance antihypertensive therapy].
    Ménard J; Corvol P; Alexandre JM; Milliez P
    Nouv Presse Med; 1974 Feb; 3(5):253-6. PubMed ID: 4362250
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of angiotensin II blockade in conscious sodium-depleted dogs.
    Stephens GA; Davis JO; Freeman RH; Watkins BE; Khosla MC
    Endocrinology; 1977 Aug; 101(2):378-8. PubMed ID: 885110
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
    Dalakos TG; Elias AN; Anderson GH; Streeten DH; Schroeder ET
    J Clin Endocrinol Metab; 1978 Jan; 46(1):114-8. PubMed ID: 752014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.
    Fyhrquist F; Kurppa K; Huuskonen M
    Acta Med Scand; 1975 Jun; 197(6):457-61. PubMed ID: 1155220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-angiotensin-aldosterone system in rabbits with thoracic caval constriction.
    Lohmeier TE; Davis JO; Hanson RC; Williams GM
    Am J Physiol; 1977 Jun; 232(6):F559-65. PubMed ID: 879290
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of long-term administration of clonidine on plasma renin activity.
    De Wurstemberger B; Gysling E
    Can Med Assoc J; 1976 Dec; 115(11):1107-8. PubMed ID: 1000443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 36. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug induced variations of the renin-angiotensin-aldosterone system in rats. II. Antihypertensives.
    Palazzoadriano M; Albano V; Bellanca L; Latteri S; Valdes L
    Pharmacol Res Commun; 1977 Nov; 9(10):955-70. PubMed ID: 605154
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
    Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 40. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.